| Phosphoproteomics |
Phosphorylation of FAK
Sites: T13, S29, Y155, S386, T388, S390, S392, Y397, T406, Y407, Y570, T700, S708, S732, S766, T793, S845, S888, S891, S894, S898, Y899, S911
| C18 (-) inhibitors | Alignment / Methods |
| IMAC (-) inhibitors | Alignment / Methods |
| C18 (+) inhibitors | Alignment / Methods |
| IMAC (+) inhibitors | Alignment / Methods |
| C18 (+) inhibitors (dup) | Alignment / Methods |
| IMAC (+) inhibitors (dup) | Alignment / Methods |
| C18 (+) inhibitors LysC | Alignment / Methods |
| C18 (+) inhibitors LysC + AspN | Alignment / Methods |
| IMAC (+) inhibitors LysC + AspN | Alignment / Methods |
| Site | Position | Peptide | ||
|---|---|---|---|---|
| (+) Inhib | (-) Inhib | |||
| 13T | 7 - 19 | DPNLNHTPSSSAK | ++ | |
| 29S | 20 - 38 | THLGTGMERSPGAMERVLK | +++ | ++++ |
| 155Y | 153 - 170 | NDYMLEIADQVDQEIALK | ++ | |
| 386S / 388T | 382 - 404 | QGVRSHTVSVSETDDYAEIIDEE | ||
| 386S / 388T | 383 - 404 | GVRSHTVSVSETDDYAEIIDEE | ||
| 386S / 390S | 381 - 393 | KQGVRSHTVSVSE | ||
| 388T / 390S | 381 - 393 | KQGVRSHTVSVSE | ||
| 388T / 392S | 382 - 404 | QGVRSHTVSVSETDDYAEIIDEE | ||
| 388T / 397Y | 382 - 404 | QGVRSHTVSVSETDDYAEIIDEE | ||
| 390S | 382 - 395 | QGVRSHTVSVSETD | ||
| 390S | 382 - 404 | QGVRSHTVSVSETDDYAEIIDEE | ++ | |
| 390S | 383 - 394 | GVRSHTVSVSET | ||
| 390S / 394T-397Y | 382 - 404 | QGVRSHTVSVSE[TDDY]AEIIDEE | ||
| 394T-397Y | 382 - 404 | QGVRSHTVSVSE[TDDY]AEIIDEE | ||
| 397Y | 382 - 404 | QGVRSHTVSVSETDDYAEIIDEE | ++ | |
| 406T / 407Y | 405 - 416 | DTYTMPSTRDYE | ||
| 570Y | 564 - 572 | DFGLSRYME | # | |
| 700T / 708S | 690 - 709 | RMRMESRRQVTVSWDSGGSD | ++++ | |
| 722S / 725S-726S | 709 - 729 | DEAPPKPSRPGYPSPR[SS]EGF | ||
| 732S | 728 - 780 | GFYPSPQHMVQPNHYQVSGYSGSHGIPAMAGSIYPGQASLLDQTDSWNHRPQE | ||
| 766S | 750 - 768 | SHGIPAMAGSIYPGQASLL | ||
| 793T | 790 - 808 | DSGTLDVRGMGQVLPTHLM | ||
| 845S | 831 - 847 | RFLVMKPDVRLSRGSIE | ||
| 888S | 877 - 896 | KPPRPGAPHLGSLASLNSPV | ++++ | |
| 888S | 877 - 904 | KPPRPGAPHLGSLASLNSPVDSYNEGVK | +++ | |
| 888S / 891S | 877 - 893 | KPPRPGAPHLGSLASLN | ||
| 888S / 891S | 877 - 896 | KPPRPGAPHLGSLASLNSPV | ||
| 888S / 891S / 894S | 877 - 896 | KPPRPGAPHLGSLASLNSPV | ||
| 888S / 894S | 877 - 896 | KPPRPGAPHLGSLASLNSPV | +++ | |
| 888S / 894S | 877 - 904 | KPPRPGAPHLGSLASLNSPVDSYNEGVK | +++ | |
| 894S | 877 - 896 | KPPRPGAPHLGSLASLNSPV | ++++ | |
| 894S | 877 - 901 | KPPRPGAPHLGSLASLNSPVDSYNE | ||
| 894S | 877 - 904 | KPPRPGAPHLGSLASLNSPVDSYNEGVK | ++ | |
| 894S / 898S | 877 - 904 | KPPRPGAPHLGSLASLNSPVDSYNEGVK | ++ | |
| 894S / 898S / 899Y | 877 - 904 | KPPRPGAPHLGSLASLNSPVDSYNEGVK | ||
| 894S / 899Y | 891 - 904 | SLNSPVDSYNEGVK | ||
| 911S | 905 - 918 | IKPQEISPPPTANL | ++++ | ++++ |
| 911S | 905 - 924 | IKPQEISPPPTANLDRSNDK | ++++ | |
*Peptides detected only by
enrichment with
immobilized metal-affinity chromatography (IMAC).
# Peptides which do not require enrichment by IMAC for detection.
